(As863) Neuroscientific Biopharmaceuticals, CEO

**02nd June, 2023**:
NeuroScientific Biopharmaceuticals (ASX:NSB) is focused on developing novel peptide-based therapeutic agents for the treatment of neurodegenerative conditions with high unmet medical need.

Working collaboratively with the Board and scientific advisors, you will ensure the achievement of the company’s long-term strategy on behalf of shareholders, and for the benefit of neurological patients.

You are an accomplished leader and executive manager in biotech, with a proven track record in drug development, including human clinical trials, and a flair for fundraising. Familiarity with ASX compliance issues is a critical success factor. The ability to gain the support of shareholders and investors is also vital.

**Position Profile**

**About the organisation**

Neuroscientific Biopharmaceutical is an Australian public listed company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet need.

**About the role**

This is a pivotal moment in NSB’s development. The Company wishes to appoint a seasoned CEO with the experience and capability to lead the Company’s strategy and to deploy its resources and technology. The primary objective of this role will be to lead and evolve NSB such that it is effective in the evaluation, design, development and execution of the Company’s human healthcare business strategy and objectives in the best interests of all NSB’s shareholders.

You will be responsible for leading the development and execution of the Company’s long-term strategy with a view to creating shareholder value, overseeing the clinical development of NSBs technology, and working with the Board on the Company’s fundraising activities.

The new CEO will report to the Board through the Chairman, Paul Rennie, and the position will be based in Perth, Adelaide, or Melbourne.

**Position Summary**

The Chief Executive Officer (CEO) is responsible to the Board of Directors for the overall leadership and management of the NSB and the implementation of the decisions of the Board.

Specifically, the role is responsible for the company’s short and long-term commercial sustainability through clear, innovative, and engaging leadership that provides strategic and operational performance across the company as determined by agreed key performance indicators. The company is at a pivotal stage in the development of assets into the human clinical trial stage and needs good leadership and management to take forward efficiently.

The CEO must ensure that the company conducts clinical trials and associated studies, ensures the company manufactures the highest quality therapeutic products, delivers a sound and improving financial position, communicates all material matters to the Board and shareholders, provides strong staff engagement and support, and effective relationships with the company’s clients including investors and with other healthcare partners as well as relevant State and Federal agencies and academic institutions.

**Position Reports To**
**Direct**
Chair of the Board

**Number of Reports**
**Direct**
Chief Operating Officer
Director of Clinical Development

**Indirect**
None

**Key Relationships**
**Internal**
- All Board Directors
- NSB Leadership Team and other employees

***

**External**
- HREC ethics committees
- CROs
- Current and potential commercial clients
- Current and potential partners, including investors
- Relevant Government Ministers and Departments (State and Federal)
- Other stakeholders including government agencies, patient stakeholders, and research institutions

**Key Accountabilities**
- **Formulate a Vision and Strategic Direction**

**Demonstrated by /Key Performance Indicators**
- Oversee the development and execution of a current and relevant Strategic Plans
- Provide leadership to secure and execute key partnerships essential to the delivery of the company strategy
- Provide leadership to key strategic projects
- Develop strategic planning capabilities in the organisation and oversee a continuous strategic planning process.
- Recognise and analyse strategic opportunities, issues, and consequences with particular emphasis on the company’s optimal place in the neuroscience sector.
- **Build a sustainable organisation**

**Demonstrated by /Key Performance Indicators**

**Financial sustainability**
- In accordance with the delegations of the Board and working with the CFO, ensure a financially viable organisation (in concert with the overall strategic plan) through a strong corporate focus on fiscal accountabilities, operational management, and setting and achieving strategic targets and key performance indicators.
- Deliver strong financial processes, including setting of budgets and reporting frameworks to ensure clarity of the Company’s financial position. Maintain strong corporate and where applicable, clinical governance frameworks and delivery high